Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
The Medical Journal of Australia
Claire J MarshJames Kollias
Emergency Medicine Australasia : EMA
Robert Meek, Wilson Phiri
Interrater reliability of the Australasian Triage Scale for mental health patients
(opens in new tab)Emergency Medicine Australasia : EMA
Anne CreatonMelissa Wright
ANZ Journal of Surgery
Elizabeth Leonard, Kate Curtis
Internal Medicine Journal
G B S McNeillP Jenkins